NASDAQ:OM Outset Medical (OM) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free OM Stock Alerts $3.07 -0.20 (-6.12%) (As of 05/10/2024 ET) Add Compare Share Share Today's Range$2.93▼$3.2750-Day Range$1.94▼$4.1352-Week Range$1.92▼$24.13Volume1.43 million shsAverage Volume1.80 million shsMarket Capitalization$158.72 millionP/E RatioN/ADividend YieldN/APrice Target$5.42 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Outset Medical alerts: Email Address Outset Medical MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside76.4% Upside$5.42 Price TargetShort InterestBearish18.28% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.02Based on 20 Articles This WeekInsider TradingSelling Shares$96,681 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.28) to ($2.23) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.93 out of 5 starsMedical Sector832nd out of 921 stocksElectromedical Equipment Industry19th out of 21 stocks 3.2 Analyst's Opinion Consensus RatingOutset Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 3 buy ratings, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageOutset Medical has only been the subject of 2 research reports in the past 90 days.Read more about Outset Medical's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted18.28% of the outstanding shares of Outset Medical have been sold short.Short Interest Ratio / Days to CoverOutset Medical has a short interest ratio ("days to cover") of 7.7.Change versus previous monthShort interest in Outset Medical has recently increased by 10.14%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldOutset Medical does not currently pay a dividend.Dividend GrowthOutset Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OM. Previous Next 1.7 News and Social Media Coverage News SentimentOutset Medical has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 20 news articles for Outset Medical this week, compared to 2 articles on an average week.Search InterestOnly 5 people have searched for OM on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $96,681.00 in company stock.Percentage Held by InsidersOnly 3.50% of the stock of Outset Medical is held by insiders.Read more about Outset Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Outset Medical are expected to grow in the coming year, from ($2.28) to ($2.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Outset Medical is -0.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Outset Medical is -0.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOutset Medical has a P/B Ratio of 1.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Outset Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Outset Medical Stock (NASDAQ:OM)Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.Read More OM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OM Stock News HeadlinesMay 11, 2024 | insidertrades.comOutset Medical, Inc. (NASDAQ:OM) CTO Jean-Olivier Racine Sells 8,306 SharesMay 10, 2024 | finance.yahoo.comOutset Medical Inc (OM) Q1 2024 Earnings: Misses Revenue Estimates and Widens LossesMay 11, 2024 | Crypto 101 Media (Ad)The Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.May 9, 2024 | markets.businessinsider.comRBC Capital Keeps Their Hold Rating on Outset Medical (OM)May 9, 2024 | finance.yahoo.comOutset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call TranscriptMay 9, 2024 | finance.yahoo.comOutset Medical Inc (OM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...May 9, 2024 | finance.yahoo.comOutset Medical First Quarter 2024 Earnings: US$0.79 loss per share (vs US$0.90 loss in 1Q 2023)May 8, 2024 | finance.yahoo.comOutset Medical Reports First Quarter 2024 Financial ResultsMay 11, 2024 | Crypto 101 Media (Ad)The Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.May 8, 2024 | msn.comOutset Medical Non-GAAP EPS of -$0.57 misses by $0.02, revenue of $28.2M misses by $2.15MMay 8, 2024 | msn.comOM Stock Earnings: Outset Medical Misses EPS, Misses Revenue for Q1 2024May 6, 2024 | marketwatch.comOutset Medical Shares Rise 56% After FDA Grants Clearance for TabloCartMay 6, 2024 | msn.comWhy Outset Medical Shares Are Up TodayMay 6, 2024 | msn.comOutset Medical stock rallies 40% on FDA clearance of dialysis deviceMay 6, 2024 | markets.businessinsider.comWhy Outset Medical Is Rising In Pre-market?May 6, 2024 | businesswire.comOutset Medical's TabloCart with Prefiltration Receives FDA 510(k) ClearanceMay 6, 2024 | americanbankingnews.comOutset Medical (OM) to Release Quarterly Earnings on WednesdayMay 1, 2024 | businesswire.comOutset Medical to Present at Upcoming Investor ConferencesApril 19, 2024 | finance.yahoo.comOutset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024April 17, 2024 | finance.yahoo.comOutset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.April 17, 2024 | businesswire.comOutset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.April 15, 2024 | businesswire.comOutset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient CareApril 9, 2024 | investing.comOutset Medical shares get Buy rating from BTIGApril 8, 2024 | msn.comBuy Rating And Bullish Price Target Sends Small Cap SoaringApril 8, 2024 | markets.businessinsider.comOutset Medical: Overcoming Challenges with Strong Market Potential and Recurring Revenue GrowthMarch 18, 2024 | msn.comCare Plan Your Doctor Would Usually Recommend For Acute Otitis MediaMarch 13, 2024 | businesswire.comOutset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of DirectorsSee More Headlines Receive OM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/21/2024Today5/11/2024Next Earnings (Estimated)8/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:OM CUSIPN/A CIK1484612 Weboutsetmedical.com Phone669-231-8200FaxN/AEmployees480Year FoundedN/APrice Target and Rating Average Stock Price Target$5.42 High Stock Price Target$6.00 Low Stock Price Target$3.00 Potential Upside/Downside+76.4%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($3.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-172,800,000.00 Net Margins-134.93% Pretax Margin-132.14% Return on Equity-108.92% Return on Assets-52.20% Debt Debt-to-Equity Ratio1.06 Current Ratio5.26 Quick Ratio4.37 Sales & Book Value Annual Sales$130.38 million Price / Sales1.22 Cash FlowN/A Price / Cash FlowN/A Book Value$2.45 per share Price / Book1.25Miscellaneous Outstanding Shares51,700,000Free Float49,892,000Market Cap$158.72 million OptionableNot Optionable Beta1.85 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMs. Leslie L. Trigg (Age 53)President, CEO & Chairman Comp: $1.22MMr. Nabeel Ahmed (Age 48)Chief Financial Officer Comp: $654.74kMr. John L. Brottem (Age 49)General Counsel & Secretary Comp: $594.15kMr. Marc Nash (Age 35)Senior Vice President of Operations and R&D Mr. Jean-Olivier Racine (Age 42)Chief Technology Officer Comp: $540.93kMr. James S. MazzolaHead of Investor RelationsNicole ShannonDirector of Marketing CommunicationsDr. Michael Aragon M.D.Chief Medical OfficerMr. Mark Gordon M.S. (Age 67)Chief Regulatory & Quality Officer More ExecutivesKey CompetitorsSemler ScientificNASDAQ:SMLRElectromedNYSE:ELMDAxoGenNASDAQ:AXGNEdap TmsNASDAQ:EDAPFONARNASDAQ:FONRView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Sold 1,048,147 shares on 5/10/2024Ownership: 5.596%Acadian Asset Management LLCBought 613,229 shares on 5/10/2024Ownership: 1.507%Jean-Olivier RacineSold 8,306 sharesTotal: $27,160.62 ($3.27/share)State Board of Administration of Florida Retirement SystemBought 4,720 shares on 5/9/2024Ownership: 0.036%GSA Capital Partners LLPBought 26,254 shares on 5/3/2024Ownership: 1.046%View All Insider TransactionsView All Institutional Transactions OM Stock Analysis - Frequently Asked Questions Should I buy or sell Outset Medical stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares. View OM analyst ratings or view top-rated stocks. What is Outset Medical's stock price target for 2024? 6 Wall Street analysts have issued 12 month price targets for Outset Medical's shares. Their OM share price targets range from $3.00 to $6.00. On average, they anticipate the company's stock price to reach $5.42 in the next year. This suggests a possible upside of 76.4% from the stock's current price. View analysts price targets for OM or view top-rated stocks among Wall Street analysts. How have OM shares performed in 2024? Outset Medical's stock was trading at $5.41 at the beginning of 2024. Since then, OM shares have decreased by 43.3% and is now trading at $3.07. View the best growth stocks for 2024 here. When is Outset Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024. View our OM earnings forecast. How were Outset Medical's earnings last quarter? Outset Medical, Inc. (NASDAQ:OM) posted its quarterly earnings results on Wednesday, February, 21st. The company reported ($0.77) earnings per share for the quarter, missing the consensus estimate of ($0.74) by $0.03. The firm had revenue of $30.51 million for the quarter, compared to analysts' expectations of $30.40 million. Outset Medical had a negative trailing twelve-month return on equity of 108.92% and a negative net margin of 134.93%. What ETFs hold Outset Medical's stock? ETFs with the largest weight of Outset Medical (NASDAQ:OM) stock in their portfolio include Procure Disaster Recovery Strategy ETF (FIXT).Procure Disaster Recovery Strategy ETF (FEMA). What guidance has Outset Medical issued on next quarter's earnings? Outset Medical issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $145.0 million-$153.0 million, compared to the consensus revenue estimate of $148.2 million. When did Outset Medical IPO? Outset Medical (OM) raised $175 million in an initial public offering (IPO) on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. Who are Outset Medical's major shareholders? Outset Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (5.60%), Assenagon Asset Management S.A. (1.83%), Acadian Asset Management LLC (1.51%), GSA Capital Partners LLP (1.05%), Griffin Asset Management Inc. (0.19%) and State Board of Administration of Florida Retirement System (0.04%). Insiders that own company stock include D Keith Grossman, James F Hinrichs, James F Hinrichs, Jean-Olivier Racine, John L Brottem, John L Brottem, Leslie Trigg, Marc Nash, Martin Vazquez, Nabeel Ahmed, Rebecca Chambers, Stacey L Porter and Steven S Williamson. View institutional ownership trends. How do I buy shares of Outset Medical? Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:OM) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeElon to Transform U.S. Economy? Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outset Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
